How to Reduce the Risk of Diabetes in Patients Being Treated for High Cholesterol-Related Diseases

摘要

Disclosed herein are compositions comprising fixed doses of ETC-1002, ezetimibe and a statin, and methods of treating a subject comprising administering fixed doses of ETC-1002, ezetimibe and a statin. Also disclosed herein is a method of administering a fixed dose of ETC-1002 or ezetimibe or both to a statin intolerant patient or a patient receiving statin therapy, wherein the administration reduces the likelihood of exacerbation of diabetes in the subject or in the subject. Reduces the increased likelihood of new onset diabetes. The methods disclosed herein also include methods of treating hypercholesterolemia and cardiovascular disease in a subject.